[1] 秦资凡, 王保和. 中药蟾酥的研究进展概况[J]. 中国药物评价, 2014, 31(5):306-309. doi:  10.3969/j.issn.2095-3593.2014.05.016
[2] 吴喜燕, 高慧敏, 王智民. 蟾蜍类药材化学成分研究进展[J]. 中国实验方剂学杂志, 2010, 16(14):207-214, 220. doi:  10.3969/j.issn.1005-9903.2010.14.066
[3] NOGAWA T, KAMANO Y, YAMASHITA A, et al. Isolation and structure of five new cancer cell growth inhibitory bufadienolides from the Chinese traditional drug Ch'an Su[J]. J Nat Prod,2001,64(9):1148-1152. doi:  10.1021/np0101088
[4] HOU W, HUANG Z X, XU H G, et al. Hybrids of arenobufagin and benzoisoselenazol reducing the cardiotoxicity of arenobufagin[J]. Bioorg Med Chem Lett,2018,28(20):3391-3394. doi:  10.1016/j.bmcl.2018.08.038
[5] HAN L Y, YUAN B, SHIMADA R, et al. Cytocidal effects of arenobufagin and hellebrigenin, two active bufadienolide compounds, against human glioblastoma cell line U-87[J]. Int J Oncol,2018,53(6):2488-2502.
[6] PERERA CÓRDOVA W H, LEITÃO S G, CUNHA-FILHO G, et al. Bufadienolides from parotoid gland secretions of Cuban toad Peltophryne fustiger (Bufonidae): Inhibition of human kidney Na(+)/K(+)-ATPase activity[J]. Toxicon,2016,110:27-34. doi:  10.1016/j.toxicon.2015.11.015
[7] WEI X, YANG J, MAO Y, et al. Arenobufagin inhibits the phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin pathway and induces apoptosis and autophagy in pancreatic cancer cells[J]. Pancreas,2020,49(2):261-272. doi:  10.1097/MPA.0000000000001471
[8] MA B, XIAO Z Y, CHEN Y J, et al. Synthesis and structure-activity relationships study of cytotoxic bufalin 3-nitrogen-containing-ester derivatives[J]. Steroids,2013,78(5):508-512. doi:  10.1016/j.steroids.2013.02.007
[9] DENG L J, WANG L H, PENG C K, et al. Fibroblast activation protein α activated tripeptide bufadienolide antitumor prodrug with reduced cardiotoxicity[J]. J Med Chem,2017,60(13):5320-5333. doi:  10.1021/acs.jmedchem.6b01755
[10] 果德安, 吴婉莹, 栗世铀, 等. 沙蟾毒精衍生物及其制备方法、包含该衍生物的组合物、及其用途: CN110483608A[P]. 2019-11-22.